Seeing Is Believing
CYTK is currently covered by 16 analysts with an average price target of $72.4. This is a potential upside of $16.8 (30.22%) from yesterday's end of day stock price of $55.6.
Cytokinetics's activity chart (see below) currently has 155 price targets and 196 ratings on display. The stock rating distribution of CYTK is 90.8% BUY and 9.2% HOLD.
Analysts average stock forecasts to be materialized ratio is 83.37% with an average time for these price targets to be met of 369.08 days.
Highest price target for CYTK is $106, Lowest price target is $60, average price target is $72.4.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 09-Sep-2024. First documented stock forecast 18-Nov-2009.
Currently out of the existing stock ratings of CYTK, 79 are a BUY (90.8%), 8 are a HOLD (9.2%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$65
10 days ago
15/15 (100%)
$33.3 (105.05%)
538
Buy
$90
$34.12 (61.06%)
$90
10 days ago
38/46 (82.61%)
$34.17 (61.20%)
801
Buy
$71
$15.12 (27.06%)
$65
14 days ago
4/7 (57.14%)
$15.07 (26.94%)
218
Buy
$78
$22.12 (39.58%)
$78
15 days ago
10/14 (71.43%)
$23.11 (42.10%)
410
Buy
$72
$16.12 (28.85%)
$72
16 days ago
8/14 (57.14%)
$17.44 (31.96%)
256
What is CYTK (Cytokinetics) average time for price targets to be met?
Which analyst has the current highest performing score on CYTK (Cytokinetics) with a proven track record?
Which analyst has the most public recommendations on CYTK (Cytokinetics)?
Which analyst is the currently most bullish on CYTK (Cytokinetics)?
Which analyst is the currently most reserved on CYTK (Cytokinetics)?